Center-Authored Papers

Filters: Author is Jones, Robin L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Almendro V, Cheng Y-K, Randles A, Itzkovitz S, Marusyk A, Ametller E, Gonzalez-Farre X, Muñoz M, Russnes HG, Helland A et al..  2014.  Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity.. Cell reports. 6(3):514-27. Abstract
B
Bathan AJ, Constantinidou A, Pollack SM, Jones RL.  2013.  Diagnosis, prognosis, and management of leiomyosarcoma: recognition of anatomic variants.. Current opinion in oncology. 25(4):384-9. Abstract
Biermann SJ, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Butrynski JE, Cheong D, Chow W, Curry WT, Frassica DA et al..  2013.  Bone cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(6):688-723. Abstract
Bremjit PJ, Jones RL, Chai X, Kane G, Rodler ET, Loggers ET, Pollack SM, Pillarisetty VG, Mann GN.  2014.  A Contemporary Large Single-Institution Evaluation of Resected Retroperitoneal Sarcoma.. Annals of surgical oncology. 54(7):2150-8. Abstract
C
Chang AE, Mann GN, Hoch B, Loggers ET, Pollack SM, Kolokythas O, Jones RL.  2013.  Multiple liver abscess formation and primary gastrointestinal stromal tumor.. Rare tumors. 5(3):e51. Abstract
Chang AE, Chai X, Pollack SM, Loggers E, Rodler E, Dillon J, Parvathaneni U, Moe KS, Futran N, Jones RL.  2014.  Analysis of clinical prognostic factors for adult patients with head and neck sarcomas.. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 151(6):976-83. Abstract
Cheung MC, Jones RL, Judson I.  2011.  Acute liver toxicity with ifosfamide in the treatment of sarcoma: a case report.. Journal of medical case reports. 5:180.
Constantinidou A, Miah A, Pollack S, Jones RL.  2013.  New drugs and clinical trial design in advanced sarcoma: have we made any progress? Future oncology (London, England). 9(10):1409-11.
Constantinidou A, Pollack S, Loggers E, Rodler E, Jones RL.  2013.  The evolution of systemic therapy in sarcoma.. Expert review of anticancer therapy. 13(2):211-23. Abstract
Constantinidou A, Jones RL, Olmos D, Thway K, Fisher C, Al-Muderis O, Judson I.  2012.  Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour.. Acta oncologica (Stockholm, Sweden). 51(4):550-554.
Constantinidou A, Pollack SM, Jones RL.  2012.  MDM2 inhibition in liposarcoma: a step in the right direction.. The Lancet. Oncology. 13(11):1070-1.
D
Demetri GD, von Mehren M, Jones RL, Hensley ML, Schuetze SM, Staddon A, Milhem M, Elias A, Ganjoo K, Tawbi H et al..  2015.  Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
F
Ferreira BP, Rodler ET, Loggers ET, Pollack SM, Jones RL.  2012.  Systemic therapy in primary angiosarcoma of the spleen.. Rare tumors. 4(4):e55. Abstract
G
Gaston CL, Grimer RJ, Parry M, Stacchiotti S, Tos APD, Gelderblom H, Ferrari S, Baldi GG, Jones RL, Chawla S et al..  2016.  Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone.. Clinical sarcoma research. 6(1):15. Abstract
Gundle KR, Cizik AM, Jones RL, Davidson DJ.  2015.  Quality of life measures in soft tissue sarcoma.. Expert review of anticancer therapy. 15(1):95-100. Abstract
Guo Y, Chen E, Davidson DJ, Pillarisetty VG, Jones RL, Pollack SM.  2016.  The Imaging and Pathological Features of Metastatic Leiomyosarcoma in the Gallbladder.. Rare tumors. 8(4):6618. Abstract
H
Hensley ML, Patel SR, von Mehren M, Ganjoo K, Jones RL, Staddon A, Rushing D, Milhem M, Monk B, Wang G et al..  2017.  Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial.. Gynecologic oncology. Abstract
J
Jones RL, Katz D, Loggers ET, Davidson D, Rodler ET, Pollack SM.  2017.  Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma.. Medical oncology (Northwood, London, England). 34(10):167. Abstract
Jones RL, Constantinidou A, Olmos D, Thway K, Fisher C, Al-Muderis O, Scurr M, Judson IR.  2012.  Role of palliative chemotherapy in advanced epithelioid sarcoma.. American journal of clinical oncology. 35(4):351-7. Abstract
Jones RL, Olmos D, Thway K, Fisher C, Tunariu N, Postel-Vinay S, Scurr M, de Bono J, Kaye SB, Judson IR.  2011.  Clinical benefit of early phase clinical trial participation for advanced sarcoma patients.. Cancer chemotherapy and pharmacology. 68(2):423-9. Abstract
Jones RL, Constantinidou A.  2012.  The efficacy of caffeine-potentiated chemotherapy in clear cell sarcoma.. International journal of clinical oncology / Japan Society of Clinical Oncology.
Jones RL, Ferrari S, Blay JY, Navid F, Lardelli P, Alfaro V, Siguero M, Soman N, Chawla SP.  2013.  A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of Tumors.. Investigational new drugs. Abstract
Jones RL, Bendell JC, Smith DC, Diefenbach K, Lettieri J, Boix O, Lockhart CA, O'Bryant C, Moore KN.  2015.  A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer.. Cancer chemotherapy and pharmacology. Abstract
Jour G, Scarborough JD, Jones RL, Loggers E, Pollack SM, Pritchard CC, Hoch BL.  2014.  Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.. Human pathology. 45(8):1563-71. Abstract
L
Lee ATJ, Pollack SM, Huang P, Jones RL.  2017.  Phase III Soft Tissue Sarcoma Trials: Success or Failure? Current treatment options in oncology. 18(3):19. Abstract